Changes in the Relations between R & D Organizations Related to the Japanese Pharmaceutical Industry
スポンサーリンク
概要
- 論文の詳細を見る
At present the pharmaceutical industry is experiencing two significant changes. One is the increasing intensity of global competition, and the other is the rapid progress of gene-related technology. Therefore, the importance of innovation, i. e., drug discovery and development, has become an increasingly important element for firms' competitive power.The purpose of this paper is to grasp the relations between R & D organizations related to the Japanese pharmaceutical industry and to investigate the changing processes within. In many industries innovations proceed through the interaction of many organizations and institutions, especially in the industry of our concern. Thus, in this paper, the R & D system of the Japanese pharmaceutical industry is analyzed both from the organizational and institutional aspect.We obtained following results: First, a shift within some institutions-like the patent system, NHI Drug Price Revisions, the new drug approval system, caused a change in the orientation towards the discovery and development of new types of drugs. In the 1990s, the Japanese pharmaceutical firms had therefore to discover and development innovative drugs for the global market, instead for focusing only on the domestic market. Second, this orientation shift has lead to the changes of the relations between R & D organizations, i. e., industry, university, and governmental agencies. These changes appear as the increase of collaborations occurring in various stages of R & D, and the increase of collaborations with agencies abroad.
- 産業学会の論文
産業学会 | 論文
- 日本IC産業の歴史からみた品質管理と自動化の関係
- 1970年代の日本におけるIC生産の自動化
- 日本とアジア諸国とのハイテク製品貿易の構造
- わが国における産業集積に対する支援政策の展開と本質
- アジアにおける新たな経営戦略の構築と展開--相互依存度を増すASEAN・中国そしてインド